Rectal Filling During Prostate RT
Hi all,
Silly question, wanted to get your thoughts. For standard frac or hypofrac prostate RT, if I’m doing daily CBCT and fiducials, why does rectal filling matter at all? I understand the dogma - a large rectum pushes the prostate anteriorly and so you could miss anteriorly and include more rectum if aligning to bony anatomy on daily kv imaging. But I feel this was more an issue in the non CBCT era. Now, if you can just align to the prostate itself, shouldn’t daily changes in rectal...
Read more (Source: Student Doctor Network)
Source: Student Doctor Network - February 10, 2024 Category: Universities & Medical Training Authors: RadOncBeamer Tags: Radiation Oncology Source Type: forums
Re: Invasive breast cancer and breast cancer death after non-screen detected ductal carcinoma in situ from 1990 to 2018 in England: population based cohort study
(Source: BMJ Comments)
Source: BMJ Comments - February 9, 2024 Category: General Medicine Source Type: forums
Re: Oral cancers are rising in the UK
(Source: BMJ Comments)
Source: BMJ Comments - February 9, 2024 Category: General Medicine Source Type: forums
Future Prospects of Interventional Pulmonology
Hi,
I am currently a resident who is very interested in IP. Lung cancer and transplant were my original interests before discovering this field which complements my strong interests in procedures as well. I know prior threads on this topic have been here but its been been several years and the field has advanced so wanted to ask a few questions.
1. What is the job market like for IP? Is it still mainly just in academic centers with limited jobs available?
2. Is it possible to work mainly...
Read more (Source: Student Doctor Network)
Source: Student Doctor Network - February 8, 2024 Category: Universities & Medical Training Authors: surfking123 Tags: Pulmonary / Critical Care Medicine Source Type: forums
Ozempic Bull**** (again)
Mandelin Rain said:
Especially with the UA companies being chronically "understaffed" (sarcastic air quotes) and requiring 14 days for review and then 7 days to schedule a peer to peer.
This should be illegal. It's a delay tactic for cancer care. Obviously that sweet insurer lobby money will keep the grift going.
Click to expand...
Our system can’t even do anything about the ozempic situation which threatens to make us insolvent. You think policymakers are going to fix prior auth for radiation? Our form of medicine, is...
Read more (Source: Student Doctor Network)
Source: Student Doctor Network - February 7, 2024 Category: Universities & Medical Training Authors: MidwestRadOnc Tags: Radiation Oncology Source Type: forums
Re: Atypia detected during breast screening and subsequent development of cancer: observational analysis of the Sloane atypia prospective cohort in England
(Source: BMJ Comments)
Source: BMJ Comments - February 5, 2024 Category: General Medicine Source Type: forums
Job search limited to a few metro areas - advice appreciated!
Hello all,
I'm a second year fellow (no visa sponsorship required) looking to join a community or hybrid heme/onc practice. Due to my spouse's job, I am constrained to practices ideally within 1 hour of the following metro areas:
- Dallas/FW
- Denver
- Seattle
- Portland
I don't have any local contacts in these areas so I'm hoping some of you may be able to advise me on general salary expectations (all these areas are desirable and I know there can be quite a bit of heterogeneity between...
Read more (Source: Student Doctor Network)
Source: Student Doctor Network - February 4, 2024 Category: Universities & Medical Training Authors: Dohle Body Tags: Hematology / Oncology Source Type: forums
financial viability study for a new RT department
Dear colleagues,
i would be grateful if you can recommend any useful resource, articles, tutorial etc ... that might help me to prepare a financial viability study. some references where i can find an average estimate of ROI in radiation therapy, average operational cost per session .... (Source: Student Doctor Network)
Source: Student Doctor Network - February 1, 2024 Category: Universities & Medical Training Authors: Kroll2013 Tags: Radiation Oncology Source Type: forums
Re: Invasive breast cancer and breast cancer death after non-screen detected ductal carcinoma in situ from 1990 to 2018 in England: population based cohort study
(Source: BMJ Comments)
Source: BMJ Comments - February 1, 2024 Category: General Medicine Source Type: forums
Palmetto/CMS/LCD not covering R sided IMRT APBI
Has anyone else seen this?
I'm seeing that in spite of NCCN saying 30/5 IMRT is the preferred APBI approach, Palmetto (the LCD for a huge chunk of the country) is not covering IMRT even for APBI in R sided breast cases.
Is this correct?
Is this something that is amenable to any appeals?
Absolutely insane that a relatively cheap treatment, proven in a phase 3 trial, listed in NCCN guidelines as the preferred technique/fractionation....is not paid for by cms. (Source: Student Doctor Network)
Source: Student Doctor Network - January 31, 2024 Category: Universities & Medical Training Authors: BobbyHeenan Tags: Radiation Oncology Source Type: forums
what is your thought about this drug pricing article?
If I interpret the data correctly, the difference in % is huge, not sure how to interpret the dollar difference. How can physician practice survive and still get a good pay given the much upper hand hospital systems have in profiting from the drug? Would love to know others perspective/experience. (Source: Student Doctor Network)
Source: Student Doctor Network - January 31, 2024 Category: Universities & Medical Training Authors: HemOncCheng Tags: Hematology / Oncology Source Type: forums
Finding all cases: not the goal of cancer screening
(Source: BMJ Comments)
Source: BMJ Comments - January 29, 2024 Category: General Medicine Source Type: forums
Re: Invasive breast cancer and breast cancer death after non-screen detected ductal carcinoma in situ from 1990 to 2018 in England: population based cohort study
(Source: BMJ Comments)
Source: BMJ Comments - January 29, 2024 Category: General Medicine Source Type: forums
High Risk Prostate - GETUG 18 - Conventional fractionation - Improved OS
Conventional EBRT to 80 Gy with 3 yrs ADT improves OS in high risk prostate ca.
Overall survival was improved, ergo a surrogate for OS in prostate radiotherapy not needed.
I imagine these results are going to stir the pot in the rad onc community.
Conventional fractionation has the data. Hypofractionation does not - would "not be proper to do so".
Hats off to the French.
ASCO GU 2024 GETUG 18
The abstract:
ASCO 2024
Long-term results of dose escalation...
Read more (Source: Student Doctor Network)
Source: Student Doctor Network - January 27, 2024 Category: Universities & Medical Training Authors: SneakyBooger Tags: Radiation Oncology Source Type: forums
what steps to take to become a doctor who does research
$(document).ready(function() {
window.TSRDataLayer = window.TSRDataLayer || [];
window.TSRDataLayer.push({
event: {
eventType: 'visible',
eventData: {
group: 'pm',
section: 'pm-content',
pmId: ,
pmTextId: ,
}
}
})
$("#reply_pm .post-content a").on("click", function() {
window.TSRDataLayer.push({
event: {
eventType: 'click',
eventData: {
group: 'pm',
section: 'pm-content',
item: 'link',
url: this.href,
pmId: ,
...
Source: The Student Room - January 25, 2024 Category: Universities & Medical Training Authors: artful_lounger Tags: Medicine Source Type: forums
